Total Return chart GlycoNex Incorporation

Stocks

End-of-day quote Taipei Exchange Other stock markets 2026-06-18			5-day change	1st Jan Change
25.30 ^TWD	-0.39%		-5.60%	-1.75%

06-10	Glyconex Announces Positive Topline Results for Phase III Clinical Trial of Denosumab Biosimilar Spd8	CI
05-14	GlycoNex Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

2013-08-04	Annual 0.015 TWD
2012-06-24	Annual 0.02 TWD